This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peace, B. E. Articles by Waltz, S. E. Search for Related Content PubMed PubMed Citation Articles by Peace, B. E. Articles by Waltz, S. E.

Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer

Departments of ¹ Surgery and ² Pediatrics, University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Requests for reprints: Susan E. Waltz, Department of Surgery, Division of Research, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0558. Phone: 513-558-8675; Fax: 513-558-8677; E-mail: susan.waltz{at}uc.edu.

The tyrosine kinase receptor Ron has been implicated in several types of cancer, including overexpression in human breast cancer. This is the first report describing the effect of Ron signaling on tumorigenesis and metastasis in a mouse model of breast cancer. Mice with a targeted deletion of the Ron tyrosine kinase signaling domain (TK–/–) were crossed to mice expressing the polyoma virus middle T antigen (pMT) under the control of the mouse mammary tumor virus promoter. Both pMT-expressing wild-type control (pMT+/– TK+/+) and pMT+/– TK–/– mice developed mammary tumors and lung metastases. However, a significant decrease in mammary tumor initiation and growth was found in the pMT+/– TK–/– mice compared with controls. An examination of mammary tumors showed that there was a significant decrease in microvessel density, significantly decreased cellular proliferation, and a significant increase in terminal deoxynucleotidyl transferase–mediated nick end labeling–positive staining in mammary tumor cells from the pMT+/– TK–/– mice compared with the pMT+/– TK+/+ mice. Biochemical analyses on mammary tumor lysates showed that whereas both the pMT-expressing TK+/+ and TK–/– tumors have increased Ron expression compared with normal mammary glands, the pMT-expressing TK–/– tumors have deficits in mitogen-activated protein kinase and AKT activation. These results indicate that Ron signaling synergizes with pMT signaling to induce mammary tumor formation, growth, and metastasis. This effect may be mediated in part through the regulation of angiogenesis and through proliferative and cell survival pathways regulated by mitogen-activated protein kinase and AKT.

Key Words: tyrosine kinase • Stk • hepatocyte growth factor–like protein (HGFL) • macrophage-stimulating protein (MSP) • polyoma middle T antigen

This article has been cited by other articles:

				L. Yang, L. Zhang, Q. Wu, and D. D. Boyd Unbiased Screening for Transcriptional Targets of ZKSCAN3 Identifies Integrin {beta}4 and Vascular Endothelial Growth Factor as Downstream Targets J. Biol. Chem., December 12, 2008; 283(50): 35295 - 35304. [Abstract] [Full Text] [PDF]

				Y. Zhang, P. J. Kaplan-Lefko, K. Rex, Y. Yang, J. Moriguchi, T. Osgood, B. Mattson, A. Coxon, M. Reese, T.-S. Kim, et al. Identification of a Novel Recepteur d'Origine Nantais/c-Met Small-Molecule Kinase Inhibitor with Antitumor Activity In vivo Cancer Res., August 15, 2008; 68(16): 6680 - 6687. [Abstract] [Full Text] [PDF]

				R. M. Thomas, K. Toney, C. Fenoglio-Preiser, M. P. Revelo-Penafiel, S. R. Hingorani, D. A. Tuveson, S. E. Waltz, and A. M. Lowy The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression Cancer Res., July 1, 2007; 67(13): 6075 - 6082. [Abstract] [Full Text] [PDF]

				A. L. Welm, J. B. Sneddon, C. Taylor, D. S. A. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans PNAS, May 1, 2007; 104(18): 7570 - 7575. [Abstract] [Full Text] [PDF]

				J. M. O'Toole, K. E. Rabenau, K. Burns, D. Lu, V. Mangalampalli, P. Balderes, N. Covino, R. Bassi, M. Prewett, K. J. Gottfredsen, et al. Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Res., September 15, 2006; 66(18): 9162 - 9170. [Abstract] [Full Text] [PDF]

				S. Germano, D. Barberis, M. M. Santoro, L. Penengo, A. Citri, Y. Yarden, and G. Gaudino Geldanamycins Trigger a Novel Ron Degradative Pathway, Hampering Oncogenic Signaling J. Biol. Chem., August 4, 2006; 281(31): 21710 - 21719. [Abstract] [Full Text] [PDF]

				X. Wei, L. Hao, S. Ni, Q. Liu, J. Xu, and P. H. Correll Altered Exon Usage in the Juxtamembrane Domain of Mouse and Human RON Regulates Receptor Activity and Signaling Specificity J. Biol. Chem., December 2, 2005; 280(48): 40241 - 40251. [Abstract] [Full Text] [PDF]

				X. Wei, S. Ni, and P. H. Correll Uncoupling Ligand-dependent and -independent Mechanisms for Mitogen-activated Protein Kinase Activation by the Murine Ron Receptor Tyrosine Kinase J. Biol. Chem., October 21, 2005; 280(42): 35098 - 35107. [Abstract] [Full Text] [PDF]